Omnicell Inc (OMCL)
Official siteHEALTHCARE • HEALTH INFORMATION SERVICES • NASDAQ
Market Cap: $1.61B
Last updated: Nov 17, 2026 at 11:06 AM ET
Omnicell Inc (OMCL) P/E Ratio & Valuation History
Omnicell (OMCL) trades at 17.6x trailing earnings and 1.3x sales. Its P/E of 17.6x is below its 5-year median of 21.6x. Its forward P/E is 29.5x. The median P/E across 7 similar companies is 35.4x.
Current Multiples
Its forward P/E is above its trailing P/E, which implies earnings per share about 40.3% lower over the next year. PEG is left out because the growth rate behind it, P/E divided by PEG, is under 2% a year.
| Multiple | Value |
|---|---|
| P/E (trailing) | 17.6x |
| Forward P/E | 29.5x |
| Price to sales | 1.3x |
| Price to book | 1.2x |
| EV/EBITDA | 9.7x |
| Price to FCF | 11.2x |
| EV/FCF | 10.2x |
| PEG | N/A |
| FCF yield | 9.0% |
Historical Medians
Against its 10-year medians, its P/E is 38.7% below 28.7x, its P/S is 50.0% below 2.6x and its P/B is 63.6% below 3.3x.
| Multiple | Current | 5-year median | 10-year median |
|---|---|---|---|
| P/E | 17.6x | 21.6x | 28.7x |
| P/S | 1.3x | 1.7x | 2.6x |
| P/B | 1.2x | 1.6x | 3.3x |
Valuation History
Over the 10 year ends shown, its P/E ranged from 16.8x in 2022 to 47.5x in 2021.
| Year end | Price | P/E | P/S | P/B |
|---|---|---|---|---|
| 2025 | $45.30 | 28.0x | 1.8x | 1.7x |
| 2024 | $44.52 | 26.2x | 1.8x | 1.7x |
| 2023 | $37.63 | 19.7x | 1.5x | 1.4x |
| 2022 | $50.42 | 16.8x | 1.7x | 2.0x |
| 2021 | $180.44 | 47.5x | 7.2x | 7.8x |
| 2020 | $120.02 | 47.3x | 5.8x | 5.5x |
| 2019 | $81.72 | 29.1x | 3.8x | 4.2x |
| 2018 | $61.24 | 29.4x | 3.1x | 3.7x |
| 2017 | $48.50 | 36.5x | 2.6x | 3.7x |
| 2016 | $33.90 | 22.6x | 1.8x | 2.9x |
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About OMCL
What is OMCL's forward P/E ratio?
Omnicell has a forward P/E ratio of 29.5x.
Is OMCL stock overvalued?
GNG's valuation label for OMCL is Undervalued. Its P/E of 17.6x compares with a median of 35.4x across 7 similar companies.
What is OMCL's price to sales ratio?
Omnicell has a price to sales ratio of 1.3x.
What is Omnicell's average P/E ratio over 5 years?
Omnicell's median P/E over the last 5 years is 21.6x, from 60 month-end values through Oct 2026.
OMCL pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts